BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17145569)

  • 1. Differential gene expression identifies subgroups of ovarian carcinoma.
    Skubitz AP; Pambuccian SE; Argenta PA; Skubitz KM
    Transl Res; 2006 Nov; 148(5):223-48. PubMed ID: 17145569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression identifies subgroups of renal cell carcinoma.
    Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
    J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
    Chien J; Fan JB; Bell DA; April C; Klotzle B; Ota T; Lingle WL; Gonzalez Bosquet J; Shridhar V; Hartmann LC
    Gynecol Oncol; 2009 Jul; 114(1):3-11. PubMed ID: 19410283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression in ovarian carcinoma: identification of potential biomarkers.
    Hibbs K; Skubitz KM; Pambuccian SE; Casey RC; Burleson KM; Oegema TR; Thiele JJ; Grindle SM; Bliss RL; Skubitz AP
    Am J Pathol; 2004 Aug; 165(2):397-414. PubMed ID: 15277215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
    Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ
    Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
    Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles in three histologic types, clear-cell, endometrioid and serous ovarian carcinomas.
    Pamuła-Piłat J; Rubel T; Rzepecka IK; Olbryt M; Herok R; Dansonka-Mieszkowska A; Grzybowska E; Kupryjańczyk J
    J Biol Regul Homeost Agents; 2014; 28(4):659-74. PubMed ID: 25620176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
    Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
    Curry EW; Stronach EA; Rama NR; Wang YY; Gabra H; El-Bahrawy MA
    Mod Pathol; 2014 Mar; 27(3):433-42. PubMed ID: 23948749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
    Meinhold-Heerlein I; Bauerschlag D; Zhou Y; Sapinoso LM; Ching K; Frierson H; Bräutigam K; Sehouli J; Stickeler E; Könsgen D; Hilpert F; von Kaisenberg CS; Pfisterer J; Bauknecht T; Jonat W; Arnold N; Hampton GM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):458-66. PubMed ID: 17255266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.
    Collins Y; Tan DF; Pejovic T; Mor G; Qian F; Rutherford T; Varma R; McQuaid D; Driscoll D; Jiang M; Deeb G; Lele S; Nowak N; Odunsi K
    Int J Mol Med; 2004 Jul; 14(1):43-53. PubMed ID: 15202015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression analysis of ovarian cancer in a population isolate.
    Grazio D; Pichler I; Fuchsberger C; Zolezzi F; Guarnieri P; Heidegger H; Scherer A; Engl B; Messini S; Egarter-Vigl E; Pramstaller PP
    Eur J Gynaecol Oncol; 2008; 29(4):357-63. PubMed ID: 18714569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.
    Skubitz KM; Pambuccian S; Manivel JC; Skubitz AP
    J Transl Med; 2008 May; 6():23. PubMed ID: 18460215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
    Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
    Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.